Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 301781, 7 pages
http://dx.doi.org/10.1155/2015/301781
Research Article

Immunohistochemical Expression of Survivin and Its Relationship with Cell Apoptosis and Proliferation in Ameloblastomas

1Research Department, School of Dentistry, Universidad Juárez del Estado de Durango (UJED), 34000 Durango, Mexico
2Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, 04960 Mexico City, Mexico
3Health Care Department, Universidad Autónoma Metropolitana, Xochimilco, 04960 Mexico City, Mexico
4Department of Biology of Reproduction, Universidad Autónoma Metropolitana, Iztapalapa, 09340 Mexico City, Mexico
5Society for Fight Against Cancer, Portoviejo, 130105 Manabi, Ecuador
6National Institute of Oncology and Radiobiology, 10400 La Habana, Cuba
7School of Dentistry, Universidad de la República (UDELAR), 19200 Montevideo, Uruguay

Received 25 November 2014; Revised 25 February 2015; Accepted 9 March 2015

Academic Editor: Lance A. Liotta

Copyright © 2015 Rogelio González-González et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kumamoto and K. Ooya, “Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas,” Virchows Archiv, vol. 444, no. 2, pp. 164–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L. R. Eversole, “Malignant epithelial odontogenic tumors,” Seminars in Diagnostic Pathology, vol. 16, no. 4, pp. 317–324, 1999. View at Google Scholar · View at Scopus
  3. D. G. Gardner, K. Heikinheimo, M. Shear, H. P. Philipsen, and H. Coleman, “Ameloblastomas,” in Pathology and Genetics of Head and Neck Tumours, J. W. Eveson, P. Reichart, and D. Sidransky, Eds., pp. 296–300, World Health Organization Classification of Tumours, IARC Press, Lyon, France, 2005. View at Google Scholar
  4. J. C. Reed, “Dysregulation of apoptosis in cancer,” Journal of Clinical Oncology, vol. 17, no. 9, pp. 2941–2953, 1999. View at Google Scholar · View at Scopus
  5. T. T. Renault, O. Teijido, B. Antonsson, L. M. Dejean, and S. Manon, “Regulation of Bax mitochondrial localization by Bcl-2 and Bcl-x L: keep your friends close but your enemies closer,” International Journal of Biochemistry and Cell Biology, vol. 45, no. 1, pp. 64–67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Stasikowska-Kanicka, M. Wagrowska-Danilewicz, and M. Danilewicz, “Immunohistochemical study on survivin in sinonasal tumors and its relationship with the immunoexpression of Ki67 and Bcl-2,” Folia Histochemica et Cytobiologica, vol. 51, no. 3, pp. 225–231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. L. Deveraux and J. C. Reed, “IAP family proteins: suppressors of apoptosis,” Genes and Development, vol. 13, no. 3, pp. 239–252, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Adida, P. L. Crotty, J. McGrath, D. Berrebi, J. Diebold, and D. C. Altieri, “Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation,” The American Journal of Pathology, vol. 152, no. 1, pp. 43–49, 1998. View at Google Scholar · View at Scopus
  9. N. K. Sah, Z. Khan, G. J. Khan, and P. S. Bisen, “Structural, functional and therapeutic biology of survivin,” Cancer Letters, vol. 244, no. 2, pp. 164–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Rodríguez, S. W. Span, C. G. M. Ferreira, F. A. E. Kruyt, and G. Giaccone, “CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin,” Experimental Cell Research, vol. 275, no. 1, pp. 44–53, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Stasikowska-Kanicka, M. Wagrowska-Danilewicz, and M. Danilewicz, “Immunohistochemical study on survivin in sinonasal tumors and its relationship with the immunoexpression of Ki67 and Bcl-2,” Folia Histochemica et Cytobiologica, vol. 51, no. 3, pp. 225–231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. L. L. Loro, O. K. Vintermyr, and A. C. Johannessen, “Apoptosis in normal and diseased oral tissues,” Oral Diseases, vol. 11, no. 5, pp. 274–287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kumamoto and K. Ooya, “Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas,” Journal of Oral Pathology and Medicine, vol. 34, no. 9, pp. 565–572, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Abdel-Aziz and M. M. Amin, “EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence,” Diagnostic Pathology, vol. 7, no. 1, article 14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Sah, A. Menon, A. Kamath, C. Chandrashekar, S. Carnelio, and R. Radhakrishnan, “Role of immunomarkers in the clinicopathological analysis of unicystic ameloblastoma,” Disease Markers, vol. 35, no. 5, pp. 481–488, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Gerdes, U. Schwab, H. Lemke, and H. Stein, “Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation,” International Journal of Cancer, vol. 31, no. 1, pp. 13–20, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Gerdes, H. Lemke, and H. Baisch, “Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67,” The Journal of Immunology, vol. 133, no. 4, pp. 1710–1715, 1984. View at Google Scholar · View at Scopus
  18. T. Scholzen and J. Gerdes, “The Ki-67 protein: from the known and the unknown,” Journal of Cellular Physiology, vol. 182, no. 3, pp. 311–322, 2000. View at Publisher · View at Google Scholar
  19. C. Ledesma-Montes, A. Mosqueda-Taylor, R. Carlos-Bregni et al., “Ameloblastomas: a regional Latin-American multicentric study,” Oral Diseases, vol. 13, no. 3, pp. 303–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Bologna-Molina, A. Mosqueda-Taylor, E. Lopez-Corella et al., “Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas,” Oral Oncology, vol. 44, no. 8, pp. 805–811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Dhanuthai, S. Chantarangsu, S. Rojanawatsirivej et al., “Ameloblastoma: a multicentric study,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 113, no. 6, pp. 782–788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C. C. Gomes, A. P. Duarte, M. G. Diniz, and R. S. Gomez, “Current concepts of ameloblastoma pathogenesis: review article,” Journal of Oral Pathology and Medicine, vol. 39, no. 8, pp. 585–591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Hockenbery, M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer, “Bcl2 protein is topographically restricted in tissues characterized by apoptotic cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 16, pp. 6961–6965, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Sandra, N. Nakamura, T. Mitsuyasu, Y. Shiratsuchi, and M. Ohishi, “Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre),” Histopathology, vol. 39, no. 1, pp. 93–98, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Ambrosini, C. Adida, and D. C. Altieri, “A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma,” Nature Medicine, vol. 3, no. 8, pp. 917–921, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Qi, Y. Kudo, T. Ando et al., “Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B,” Oral Oncology, vol. 46, no. 4, pp. 263–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Sui, Y. Dong, M. Ohno, Y. Watanabe, K. Sugimoto, and M. Tokuda, “Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.,” International journal of oncology, vol. 21, no. 2, pp. 315–320, 2002. View at Google Scholar · View at Scopus
  28. C. Jane, A. V. Nerurkar, N. V. Shirsat, R. B. Deshpande, A. D. Amrapurkar, and F. R. Karjodkar, “Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers,” Journal of Oral Pathology and Medicine, vol. 35, no. 10, pp. 595–601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Marioni, A. Bedogni, L. Giacomelli et al., “Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas,” Acta Oto-Laryngologica, vol. 125, no. 11, pp. 1218–1223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Soluk Tekkeşin, S. Mutlu, and V. Olgaç, “Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic odontogenic tumor) in comparison with ameloblastomas and radicular cysts,” Turkish Journal of Pathology, vol. 28, no. 1, pp. 49–55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Mitsuyasu, H. Harada, Y. Higuchi et al., “Immunohistochemical demonstration of bcl-2 protein in ameloblastoma,” Journal of Oral Pathology and Medicine, vol. 26, no. 8, pp. 345–348, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Lalier, P.-F. Cartron, P. Juin et al., “Bax activation and mitochondrial insertion during apoptosis,” Apoptosis, vol. 12, no. 5, pp. 887–896, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Meer, J. S. Galpin, M. Altini, H. Coleman, and H. Ali, “Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 95, no. 2, pp. 213–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Rosenstein, M. A. Pogrel, R. A. Smith, and J. A. Regezi, “Cystic ameloblastoma—behavior and treatment of 21 cases,” Journal of Oral and Maxillofacial Surgery, vol. 59, no. 11, pp. 1311–1316, 2001. View at Publisher · View at Google Scholar · View at Scopus